Medicine
Explore Medicine & Drugs
Latest about Medicine & Drugs

Vaccine for superbugs? New shot shows promise in early tests
By Stephanie Pappas published
A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

Shroom compound psilocybin shows promise for bipolar disorder in early trial
By Nicoletta Lanese published
An early trial hints that psilocybin could be a safe and effective treatment for depressive episodes in bipolar II disorder and should be studied further.

Blood thickening tied to gender-affirming testosterone is rare
By Emily Cooke published
Trans and gender-diverse people people who take testosterone face a risk of blood thickening, but the largest study to date in the U.S. suggests that this side effect is rare.

CRISPR therapy for high cholesterol shows promise in early trial
By Nicoletta Lanese published
Using a CRISPR-guided technique called "base editing," scientists edited the genes of liver cells in 10 people's bodies.

FDA approves world's 1st chikungunya vaccine
By Nicoletta Lanese published
There's now an FDA-approved vaccine for chikungunya, a mosquito-spread virus that can cause fever, severe joint pain, and rarely, death.

Antibiotics growing gravely ineffective for childhood infections
By Emily Cooke published
A study found that many common antibiotics were less than 50% effective at treating serious bacterial infections in children and newborn babies in the Asia-Pacific.

CBD reportedly discovered in plant that's not cannabis
By Emily Cooke published
Scientists say they've discovered CBD in a shrub that belongs to the same family as cannabis, although they've yet to publish the research.

Do traditional Chinese herbs actually 'heal'? This tool aims to find out.
By Emily Cooke published
A new tool may be able to predict the effectiveness of herbs used in traditional Chinese medicines — but what do experts think of its assessments?

RSV drug shortage prompts CDC to adjust recommendations
By Nicoletta Lanese published
A new antibody shot called Beyfortus was recently approved to protect babies from RSV, but it's in short supply this season.

Will we still have antibiotics in 50 years? 7 experts weigh in
By Lori L. Burrows, Yori Yuliandra, Fidelma Fitzpatrick, Roy Robins-Browne, Raúl Rivas González, Juliana Côrrea, André O. Hudson published
Experts across public health, microbiology and biochemistry agree that we'll still have antibiotics in 50 years, but the drugs may take a different form than those we have today.
Sign up for the Live Science daily newsletter now
Get the world’s most fascinating discoveries delivered straight to your inbox.